| Availability: | |
|---|---|
200 uints
Nabota®
Nabota 200 ui is a highly purified botulinum toxin type A product developed by Daewoong Pharmaceutical, a leading South Korean biopharmaceutical company. Known for its safety, consistency, and rapid onset, Nabota has gained global recognition and is FDA-approved in the United States under the brand name Jeuveau®.
Nabota is used by licensed medical professionals for both aesthetic and therapeutic applications, offering predictable, long-lasting results with a low risk of immunogenicity.
Active Ingredient: Clostridium botulinum toxin type A (200 units)
Excipients: Human serum albumin, sodium chloride
High Purity: Manufactured using Hi-PURE™ technology for consistent potency and minimal impurities.
Fast Onset: Visible results typically within 2–3 days.
Long-Lasting Effects: Clinical duration of 4–6 months.
Low Antibody Formation Risk: Advanced purification reduces risk of resistance over time.
Proven Safety Profile: Supported by global clinical trials and FDA/EMA approvals.
Simple Procedure - Just by few tiny injections
Short Treatment - 30 minutes
No Down Time - Resume normal work right away
Supplied as a white lyophilized powder in a clear vial.
Reconstitute with 0.9% sterile saline (non-preserved) to desired concentration.
Common dilution: 2.5 mL saline → 8 units per 0.1 mL
Use immediately after reconstitution or store refrigerated (2–8°C) for up to 24 hours.
Check out how to reconstitute Nabota Botulinum Toxin.
Nabota works by blocking the release of acetylcholine at the neuromuscular junction, resulting in temporary muscle paralysis or relaxation. This effect helps reduce dynamic wrinkles or manage muscle hyperactivity, depending on the treatment area.
Glabellar lines (FDA-approved)
Forehead wrinkles
Crow's feet
Bunny lines
Jawline contouring (masseter reduction)
Neck bands
Brow lift
Note: Only glabellar lines are FDA-approved; other uses are considered off-label and must be administered by qualified professionals.
Chronic migraine
Muscle spasticity
Blepharospasm
Cervical dystonia
Hyperhidrosis (excessive sweating)
Intramuscular or intradermal injection by licensed healthcare providers.
Individualized dosage and injection sites based on patient condition and indication.
Avoid injecting into blood vessels or areas of infection/inflammation.
Before reconstitution: Store at 2–8°C, protected from light.
After reconstitution: Use within 24 hours, stored at 2–8°C.
Shelf life: 36 months from manufacture (unopened vial)
Only for use by trained medical professionals.
Do not use in patients with known hypersensitivity to botulinum toxin or its components.
Avoid in patients with neuromuscular disorders (e.g., ALS, myasthenia gravis).
Monitor for potential reactions including injection site effects, headache, ptosis, or rare systemic symptoms.
Rare: systemic botulinum toxin effects (dysphagia, respiratory weakness)
Dermax supplies authentic Nabota 200ui directly from South Korea with:
Wholesale pricing for professionals
Cold-chain logistics to preserve product integrity
No minimum order required
Responsive customer service and documentation support
Contact us today for pricing, shipping, and clinical guidance.
Disclaimer: Please note that packaging designs may vary. Our products are intended for licensed medical professionals only. By purchasing, you agree to provide proof of credentials if requested. These medical devices are not for personal or home use. Please review all instructions carefully to understand contraindications and precautions.
Since almost 20 years Dermax has been innovating the world with aesthetic and medical treatment solutions. Dermax develops and manufactures a diverse range oflead ing applications for facial countouring. skin revitallization, wrinkle reduction, body contouring.and more, Our innovatve products are used worldwide by practitioners. physicians,and aesthetic business owrers to help enhance their offetings while pro viding the satisfactory treatments to patients.
Good Manufacturing Practices (GMP) provides manufacturing, testing, and quality assurance, which ensures that products from Dermax are safe for human consumption or use. Approved by CE, ISO, SFDA, products are consistently in high quality.
Nabota is manufactured by Daewoong Pharmaceutical in South Korea. In the United States, the same botulinum toxin formulation is marketed as Jeuveau®, which is FDA-approved for treating glabellar lines. Approval status may vary by country.
Nabota is produced by Daewoong Pharmaceutical using its Hi-PURE™ purification technology. The product is manufactured under GMP standards to ensure consistent quality, purity, and potency.
A common dilution is 2.5 mL of preservative-free 0.9% saline, providing approximately 8 units per 0.1 mL. Healthcare professionals may adjust the dilution according to the treatment area and injection technique.
Initial effects are usually visible within 2–3 days, with full results developing after 10–14 days. The onset may vary depending on the treatment area and individual patient response.
Results typically last between 4 and 6 months. Duration depends on factors such as dosage, muscle activity, injection technique, and individual metabolism.
Both Nabota and Botox Brand contain botulinum toxin type A and are used for aesthetic and therapeutic treatments. Nabota is recognized for its high purity, rapid onset, and consistent clinical performance.
Yes. Nabota is widely used by qualified healthcare professionals for masseter reduction and facial contouring. In many regions, this is considered an off-label indication.
Yes. Dermax supplies authentic Nabota 200 Units for licensed clinics, hospitals, and distributors with competitive wholesale pricing, cold-chain shipping, and professional customer support.
